Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Surveillance of Microsporidia and Protozoan Pathogens in Pensacola Florida: A One-year Study.

Moss JA, Snyder RA.

J Eukaryot Microbiol. 2018 Dec 17. doi: 10.1111/jeu.12708. [Epub ahead of print]

PMID:
30556931
2.

Using Simulation to Teach Telehealth Nursing Competencies.

Smith TS, Watts P, Moss JA.

J Nurs Educ. 2018 Oct 1;57(10):624-627. doi: 10.3928/01484834-20180921-10.

PMID:
30277549
3.

Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial.

Vincent KL, Moss JA, Marzinke MA, Hendrix CW, Anton PA, Pyles RB, Guthrie KM, Dawson L, Olive TJ, Butkyavichene I, Churchman SA, Cortez JM Jr, Fanter R, Gunawardana M, Miller CS, Yang F, Rosen RK, Vargas SE, Baum MM.

PLoS Med. 2018 Sep 28;15(9):e1002655. doi: 10.1371/journal.pmed.1002655. eCollection 2018 Sep.

4.

A Competency-Based Curriculum for Critical Care Nurse Practitioners' Transition to Practice.

Kopf RS, Watts PI, Meyer ES, Moss JA.

Am J Crit Care. 2018 Sep;27(5):398-406. doi: 10.4037/ajcc2018101.

PMID:
30173173
5.

The effect of data-entry template design and anesthesia provider workload on documentation accuracy, documentation efficiency, and user-satisfaction.

Wilbanks BA, Berner ES, Alexander GL, Azuero A, Patrician PA, Moss JA.

Int J Med Inform. 2018 Oct;118:29-35. doi: 10.1016/j.ijmedinf.2018.07.006. Epub 2018 Jul 24.

PMID:
30153918
6.

Phase I trial of pod-intravaginal rings delivering antiretroviral agents for HIV-1 prevention: Rectal drug exposure from vaginal dosing with tenofovir disoproxil fumarate, emtricitabine, and maraviroc.

Vincent KL, Moss JA, Marzinke MA, Hendrix CW, Anton PA, Gunawardana M, Dawson LN, Olive TJ, Pyles RB, Baum MM.

PLoS One. 2018 Aug 22;13(8):e0201952. doi: 10.1371/journal.pone.0201952. eCollection 2018.

7.

Protection Efficacy of C5A Against Vaginal and Rectal HIV Challenges in Humanized Mice.

Gallay PA, Chatterji U, Kirchhoff A, Gandarilla A, Pyles RB, Baum MM, Moss JA.

Open Virol J. 2018 Feb 28;12:1-13. doi: 10.2174/1874357901812010001. eCollection 2018.

8.

Chemical evolution of atmospheric organic carbon over multiple generations of oxidation.

Isaacman-VanWertz G, Massoli P, O'Brien R, Lim C, Franklin JP, Moss JA, Hunter JF, Nowak JB, Canagaratna MR, Misztal PK, Arata C, Roscioli JR, Herndon ST, Onasch TB, Lambe AT, Jayne JT, Su L, Knopf DA, Goldstein AH, Worsnop DR, Kroll JH.

Nat Chem. 2018 Apr;10(4):462-468. doi: 10.1038/s41557-018-0002-2. Epub 2018 Feb 26.

9.

Who Needs a Pediatric Intensive Care Unit After Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis?

Haber LL, Womack ED, Sathyamoorthy M, Moss JA, Shrader MW.

Spine Deform. 2018 Mar - Apr;6(2):137-140. doi: 10.1016/j.jspd.2017.08.006. Epub 2017 Oct 5.

PMID:
29413735
10.

Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque model.

Smith JM, Moss JA, Srinivasan P, Butkyavichene I, Gunawardana M, Fanter R, Miller CS, Sanchez D, Yang F, Ellis S, Zhang J, Marzinke MA, Hendrix CW, Kapoor A, Baum MM.

PLoS One. 2017 Oct 5;12(10):e0185946. doi: 10.1371/journal.pone.0185946. eCollection 2017.

11.

Prevention of vaginal and rectal HIV transmission by antiretroviral combinations in humanized mice.

Gallay PA, Chatterji U, Kirchhoff A, Gandarilla A, Gunawardana M, Pyles RB, Marzinke MA, Moss JA, Baum MM.

PLoS One. 2017 Sep 7;12(9):e0184303. doi: 10.1371/journal.pone.0184303. eCollection 2017.

12.

Pharmacokinetics and Preliminary Safety of Pod-Intravaginal Rings Delivering the Monoclonal Antibody VRC01-N for HIV Prophylaxis in a Macaque Model.

Zhao C, Gunawardana M, Villinger F, Baum MM, Remedios-Chan M, Moench TR, Zeitlin L, Whaley KJ, Bohorov O, Smith TJ, Anderson DJ, Moss JA.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e02465-16. doi: 10.1128/AAC.02465-16. Print 2017 Jul.

13.

An intravaginal ring for real-time evaluation of adherence to therapy.

Moss JA, Baum MM, Easley JT, Cox DM, Smith TJ.

PLoS One. 2017 Apr 6;12(4):e0174729. doi: 10.1371/journal.pone.0174729. eCollection 2017.

14.

Biofilms for Monitoring Presence of Microsporidia in Environmental Water.

Moss JA, Snyder RA.

J Eukaryot Microbiol. 2017 Jul;64(4):533-538. doi: 10.1111/jeu.12390. Epub 2017 Jan 29.

PMID:
27995672
15.

Waterborne Pathogens: The Protozoans.

Moss JA.

Radiol Technol. 2016 Sep;88(1):27-48. Review.

PMID:
27601690
16.

Ambient Gas-Particle Partitioning of Tracers for Biogenic Oxidation.

Isaacman-VanWertz G, Yee LD, Kreisberg NM, Wernis R, Moss JA, Hering SV, de Sá SS, Martin ST, Alexander ML, Palm BB, Hu W, Campuzano-Jost P, Day DA, Jimenez JL, Riva M, Surratt JD, Viegas J, Manzi A, Edgerton E, Baumann K, Souza R, Artaxo P, Goldstein AH.

Environ Sci Technol. 2016 Sep 20;50(18):9952-62. doi: 10.1021/acs.est.6b01674. Epub 2016 Sep 2.

PMID:
27552285
17.

From Checklist to Awareness: Hearing God's Call to Missions.

Snead V, Moss JA.

J Christ Nurs. 2016 Jul-Sep;33(3):159-61. doi: 10.1097/CNJ.0000000000000284.

PMID:
27295232
18.

Topical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV Exposures.

Srinivasan P, Moss JA, Gunawardana M, Churchman SA, Yang F, Dinh CT, Mitchell JM, Zhang J, Fanter R, Miller CS, Butkyavichene I, McNicholl JM, Smith TJ, Baum MM, Smith JM.

PLoS One. 2016 Jun 8;11(6):e0157061. doi: 10.1371/journal.pone.0157061. eCollection 2016.

19.

Combination Pod-Intravaginal Ring Delivers Antiretroviral Agents for HIV Prophylaxis: Pharmacokinetic Evaluation in an Ovine Model.

Moss JA, Butkyavichene I, Churchman SA, Gunawardana M, Fanter R, Miller CS, Yang F, Easley JT, Marzinke MA, Hendrix CW, Smith TJ, Baum MM.

Antimicrob Agents Chemother. 2016 May 23;60(6):3759-66. doi: 10.1128/AAC.00391-16. Print 2016 Jun.

20.

Accurate measurement of female genital tract fluid dilution in cervicovaginal lavage samples.

Churchman SA, Moss JA, Baum MM.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Apr 1;1017-1018:75-81. doi: 10.1016/j.jchromb.2016.02.033. Epub 2016 Mar 2.

21.

Veteran Competencies for Undergraduate Nursing Education.

Moss JA, Moore RL, Selleck CS.

ANS Adv Nurs Sci. 2015 Oct-Dec;38(4):306-16. doi: 10.1097/ANS.0000000000000092.

PMID:
26517342
22.

Journey to Ecuador: Simple Acts, Priceless Gifts.

Murray SN, Moss JA.

Imprint. 2015 Apr-May;62(3):30-3. No abstract available.

PMID:
26470511
23.

An intravaginal ring for the sustained delivery of tenofovir disoproxil fumarate.

Baum MM, Butkyavichene I, Churchman SA, Lopez G, Miller CS, Smith TJ, Moss JA.

Int J Pharm. 2015 Nov 10;495(1):579-587. doi: 10.1016/j.ijpharm.2015.09.028. Epub 2015 Sep 16.

24.

Pharmacokinetics of long-acting tenofovir alafenamide (GS-7340) subdermal implant for HIV prophylaxis.

Gunawardana M, Remedios-Chan M, Miller CS, Fanter R, Yang F, Marzinke MA, Hendrix CW, Beliveau M, Moss JA, Smith TJ, Baum MM.

Antimicrob Agents Chemother. 2015 Jul;59(7):3913-9. doi: 10.1128/AAC.00656-15. Epub 2015 Apr 20.

25.

Polycyclic aromatic hydrocarbon concentrations across the Florida Panhandle continental shelf and slope after the BP MC 252 well failure.

Snyder RA, Ederington-Hagy M, Hileman F, Moss JA, Amick L, Carruth R, Head M, Marks J, Tominack S, Jeffrey WH.

Mar Pollut Bull. 2014 Dec 15;89(1-2):201-208. doi: 10.1016/j.marpolbul.2014.09.057. Epub 2014 Oct 16.

PMID:
25444619
26.

Gene therapy review.

Moss JA.

Radiol Technol. 2014 Nov-Dec;86(2):155-80; quiz 181-4. Review.

PMID:
25391667
27.

Pharmacokinetics of injectable, long-acting nevirapine for HIV prophylaxis in breastfeeding infants.

Cortez JM Jr, Quintero R, Moss JA, Beliveau M, Smith TJ, Baum MM.

Antimicrob Agents Chemother. 2015 Jan;59(1):59-66. doi: 10.1128/AAC.03906-14. Epub 2014 Oct 13.

28.

Effective concentration and detection of cryptosporidium, giardia, and the microsporidia from environmental matrices.

Moss JA, Gordy J, Snyder RA.

J Pathog. 2014;2014:408204. doi: 10.1155/2014/408204. Epub 2014 Sep 10.

29.

An intravaginal ring for the sustained delivery of antibodies.

Gunawardana M, Baum MM, Smith TJ, Moss JA.

J Pharm Sci. 2014 Nov;103(11):3611-3620. doi: 10.1002/jps.24154. Epub 2014 Sep 17.

30.

Discovering the healthcare beliefs and practices of rural mestizo Ecuadorians. An ethnonursing study.

Moss JA.

Invest Educ Enferm. 2014;32(2):326-36. doi: 10.17533/udea.iee.v32n2a15.

PMID:
25230042
31.

Pharmacokinetics and preliminary safety study of pod-intravaginal rings delivering antiretroviral combinations for HIV prophylaxis in a macaque model.

Moss JA, Srinivasan P, Smith TJ, Butkyavichene I, Lopez G, Brooks AA, Martin A, Dinh CT, Smith JM, Baum MM.

Antimicrob Agents Chemother. 2014 Sep;58(9):5125-35. doi: 10.1128/AAC.02871-14. Epub 2014 Jun 16.

32.

Isolation of PCR quality microbial community DNA from heavily contaminated environments.

Gunawardana M, Chang S, Jimenez A, Holland-Moritz D, Holland-Moritz H, La Val TP, Lund C, Mullen M, Olsen J, Sztain TA, Yoo J, Moss JA, Baum MM.

J Microbiol Methods. 2014 Jul;102:1-7. doi: 10.1016/j.mimet.2014.04.005. Epub 2014 Apr 24.

PMID:
24769406
33.

Examining obstacles as a student nurse in South Africa.

Collins KR, Daves JK, Moss JA.

Imprint. 2013 Nov-Dec;60(5):38-9. No abstract available.

PMID:
24624577
34.

The fuel cell model of abiogenesis: a new approach to origin-of-life simulations.

Barge LM, Kee TP, Doloboff IJ, Hampton JM, Ismail M, Pourkashanian M, Zeytounian J, Baum MM, Moss JA, Lin CK, Kidd RD, Kanik I.

Astrobiology. 2014 Mar;14(3):254-70. doi: 10.1089/ast.2014.1140.

35.

Sustained delivery of commensal bacteria from pod-intravaginal rings.

Gunawardana M, Mullen M, Yoo J, Webster P, Moss JA, Baum MM.

Antimicrob Agents Chemother. 2014;58(4):2262-7. doi: 10.1128/AAC.02542-13. Epub 2014 Feb 3.

36.

Comparison of the vaginal microbial communities in women with recurrent genital HSV receiving acyclovir intravaginal rings.

Ursell LK, Gunawardana M, Chang S, Mullen M, Moss JA, Herold BC, Keller MJ, McDonald D, González A, Knight R, Baum MM.

Antiviral Res. 2014 Feb;102:87-94. doi: 10.1016/j.antiviral.2013.12.004. Epub 2013 Dec 19.

37.

A nurse developed toolkit for long-term care ombudsmen.

Baker NR, Jablonski RA, Moss JA.

Geriatr Nurs. 2014 Mar-Apr;35(2):111-3. doi: 10.1016/j.gerinurse.2013.10.014. Epub 2013 Oct 24.

PMID:
24246688
38.

Development of a simulated smart pump interface.

Elias BL, Moss JA, Shih A, Dillavou M.

Comput Inform Nurs. 2014 Jan;32(1):21-7; quiz 28-9. doi: 10.1097/CIN.0000000000000016.

PMID:
24189715
39.

Global expression of molecular transporters in the human vaginal tract: implications for HIV chemoprophylaxis.

Gunawardana M, Mullen M, Moss JA, Pyles RB, Nusbaum RJ, Patel J, Vincent KL, Wang C, Guo C, Yuan YC, Warden CD, Baum MM.

PLoS One. 2013 Oct 15;8(10):e77340. doi: 10.1371/journal.pone.0077340. eCollection 2013.

40.

Quantification of relative proportions of intact cells in microbiological samples using the example of Cryptosporidium parvum oocysts.

Agulló-Barceló M, Moss JA, Green J, Gillespie S, Codony F, Lucena F, Nocker A.

Lett Appl Microbiol. 2014 Jan;58(1):70-8. doi: 10.1111/lam.12157. Epub 2013 Sep 30.

41.

An observational study of the accuracy and completeness of an anesthesia information management system: recommendations for documentation system changes.

Wilbanks BA, Moss JA, Berner ES.

Comput Inform Nurs. 2013 Aug;31(8):359-67. doi: 10.1097/NXN.0b013e31829a8f4b.

PMID:
23851709
42.

Pharmacokinetics of a multipurpose pod-intravaginal ring simultaneously delivering five drugs in an ovine model.

Moss JA, Malone AM, Smith TJ, Kennedy S, Nguyen C, Vincent KL, Motamedi M, Baum MM.

Antimicrob Agents Chemother. 2013 Aug;57(8):3994-7. doi: 10.1128/AAC.00547-13. Epub 2013 Jun 10.

43.

HIV/AIDS Review.

Moss JA.

Radiol Technol. 2013 Jan-Feb;84(3):247-67; quiz p.268-70. Review.

PMID:
23322863
44.

Safety and pharmacokinetics of intravaginal rings delivering tenofovir in pig-tailed macaques.

Moss JA, Malone AM, Smith TJ, Butkyavichene I, Cortez C, Gilman J, Kennedy S, Kopin E, Nguyen C, Sinha P, Hendry RM, Guenthner P, Holder A, Martin A, McNicholl J, Mitchell J, Pau CP, Srinivasan P, Smith JM, Baum MM.

Antimicrob Agents Chemother. 2012 Nov;56(11):5952-60. doi: 10.1128/AAC.01198-12. Epub 2012 Sep 10.

45.

Design of peptide imaging agents for whole-body and intraoperative molecular imaging.

Moss JA, Vāvere AL, Azhdarinia A.

Curr Med Chem. 2012;19(20):3255-65. Review.

PMID:
22664243
46.

An intravaginal ring for the simultaneous delivery of multiple drugs.

Baum MM, Butkyavichene I, Gilman J, Kennedy S, Kopin E, Malone AM, Nguyen C, Smith TJ, Friend DR, Clark MR, Moss JA.

J Pharm Sci. 2012 Aug;101(8):2833-43. doi: 10.1002/jps.23208. Epub 2012 May 22.

47.

Safety and pharmacokinetics of aciclovir in women following release from a silicone elastomer vaginal ring.

Keller MJ, Malone AM, Carpenter CA, Lo Y, Huang M, Corey L, Willis R, Nguyen C, Kennedy S, Gunawardana M, Guerrero D, Moss JA, Baum MM, Smith TJ, Herold BC.

J Antimicrob Chemother. 2012 Aug;67(8):2005-12. doi: 10.1093/jac/dks151. Epub 2012 May 3.

48.

Tenofovir and tenofovir disoproxil fumarate pharmacokinetics from intravaginal rings.

Moss JA, Baum MM, Malone AM, Kennedy S, Kopin E, Nguyen C, Gilman J, Butkyavichene I, Willis RA, Vincent KL, Motamedi M, Smith TJ.

AIDS. 2012 Mar 27;26(6):707-10. doi: 10.1097/QAD.0b013e3283509abb.

49.

Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring.

Moss JA, Malone AM, Smith TJ, Kennedy S, Kopin E, Nguyen C, Gilman J, Butkyavichene I, Vincent KL, Motamedi M, Friend DR, Clark MR, Baum MM.

Antimicrob Agents Chemother. 2012 Feb;56(2):875-82. doi: 10.1128/AAC.05662-11. Epub 2011 Nov 28.

50.

Smart pump technology: what we have learned.

Elias BL, Moss JA.

Comput Inform Nurs. 2011 Apr;29(4 Suppl):TC61-7. doi: 10.1097/NCN.0b013e31821ef813.

PMID:
21562383

Supplemental Content

Support Center